Compound ID | 445

Update compound information

SC-002

Synonym(s): SC002  |  SC 002

Class: Beta-lactam

Agent Type: Semisynthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-positive & Gram-negative
Mechanism of action: Cell wall synthesis inhibitor
Description: Oral cephem
Institute where first reported: Taisho Pharmaceuticals, Japan
Year first mentioned: 1992
Highest development stage: Phase 1
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 477.54
Iso. SMILES: O/N=C(\C(NC1C(N2C1SCC(/C=C\C3=CSN=C3)=C2C(O)=O)=C)=O)/C4=NSC(N)=N4
InChI Key: OBCLWVHQAUXMHD-RQRJAZGMSA-N
Can. SMILES: C=C1C(C2N1C(=C(/C=C\C3=CSN=C3)CS2)C(=O)O)NC(=O)/C(=N\O)/C4=NSC(=N4)N
InChI: InChI=1S/C17H15N7O4S3/c1-7-10(20-14(25)11(22-28)13-21-17(18)31-23-13)15-24(7)12(16(26)27)9(6-29-15)3-2-8-4-19-30-5-8/h2-5,10,15,28H,1,6H2,(H,20,25)(H,26,27)(H2,18,21,23)/b3-2-,22-11-
External links:
Citations:
  • https://karger.com/che/article/47/3/157/65945/In-vitro-and-in-vivo-Antibacterial-Activity-and
  • https://www.ncbi.nlm.nih.gov/pubmed/11306784
  • https://karger.com/che/article-pdf/47/3/157/2395646/000063217.pdf

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.